Morgan Stanley

Selected news for the capital firm - Morgan Stanley, collected since 10/2017. There are 145K items in the archive. This capital firm shares healthcare news with Medical Research, Wolfe Research, UnitedHealth Group, Johnson & Johnson, Pharma and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/7/2022 DexCom (NASDAQ:DXCM) Price Target Cut to $363.00 by Analysts at Morgan Stanley wkrb13.com DexCom ( NASDAQ:DXCM – Get Rating ) had its price objective decreased by Morgan Stanley from $492.00 to $363.00 in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s target price suggests a potential upside of 19.00% from the stock’s previous close.Several other analysts have ...
6/7/2022 DexCom (NASDAQ:DXCM) Price Target Cut to $363.00 by Analysts at Morgan Stanley etfdailynews.com DexCom ( NASDAQ:DXCM – Get Rating ) had its price objective decreased by Morgan Stanley from $492.00 to $363.00 in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s target price suggests a potential upside of 19.00% from the stock’s previous close.Several other analysts have ...
6/7/2022 Voya Financial to present at the Morgan Stanley US Financials, Payments & CRE Conference | Business Wire Business Wire ... announced that Rodney O. Martin, Jr., chairman and chief executive officer; Michael Smith, vice chairman and chief financial officer; and Charles Nelson, vice chairman and chief growth officer, are scheduled to participate in the Morgan Stanley US Financials, Payments & CRE Conference on Monday, June 13, 2022, at approximately 2:30 p.m. ET.The webcast will be available at the following link on the Voya investor relations website: https://morganstanley.webcasts.com/starthere.jsp?ei ...
6/7/2022 Voya Financial to present at the Morgan Stanley US Financials, Payments & CRE Conference Business Wire ... announced that Rodney O. Martin, Jr., chairman and chief executive officer; Michael Smith, vice chairman and chief financial officer; and Charles Nelson, vice chairman and chief growth officer, are scheduled to participate in the Morgan Stanley US Financials, Payments & CRE Conference on Monday, June 13, 2022, at approximately 2:30 p.m. ET.The webcast will be available at the following link on the Voya investor relations website: https://morganstanley.webcasts.com/starthere.jsp?ei ...
6/5/2022 Cigna Investments Inc. New Sells 12,192 Shares of Morgan Stanley (NYSE:MS) - Slater Sentinel slatersentinel.com Cigna Investments Inc. New reduced its position in shares of Morgan Stanley ( NYSE:MS – Get Rating ) by 27.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,904 shares of the financial services provider’s stock after selling 12,192 shares during the quarter. Cigna Investments Inc. New’s holdings in Morgan Stanley were worth $3,131,000 as of its most recent ...
6/5/2022 Cigna Investments Inc. New Sells 12,192 Shares of Morgan Stanley (NYSE:MS) modernreaders.com Cigna Investments Inc. New reduced its position in shares of Morgan Stanley ( NYSE:MS – Get Rating ) by 27.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,904 shares of the financial services provider’s stock after selling 12,192 shares during the quarter. Cigna Investments Inc. New’s holdings in Morgan Stanley were worth $3,131,000 as of its most recent ...
6/3/2022 Slowing App Store Growth Could Hit Apple In The Near-term, Morgan Stanley Says, by Samantha Subin, CNBC CNBC Apple 's App Store is showing signs of slowing growth, which could hurt the stock in the near future, Morgan Stanley said. "While we are bullish on the longer-term App Store and Services outlook, a deceleration in App Store growth (and monetization) could be a near-term headwind to results," wrote analyst Katy Huberty in a note to clients Friday. May App Store revenue growth slowed to 4% year ...
5/31/2022 AmerisourceBergen (NYSE:ABC) Price Target Cut to $175.00 by Analysts at Morgan Stanley Dakota Financial News AmerisourceBergen ( NYSE:ABC – Get Rating ) had its price target reduced by Morgan Stanley from $178.00 to $175.00 in a report released on Friday, Stock Target Advisor reports. Morgan Stanley currently has an equal weight rating on the stock.ABC has been the topic of several other research reports. Argus boosted their price target on AmerisourceBergen from $140.00 to $160.00 in a research note on Monday, March 14th. Deutsche Bank ...
5/31/2022 Ingersoll Rand (NYSE:IR) Given New $52.00 Price Target at Morgan Stanley etfdailynews.com Ingersoll Rand ( NYSE:IR – Get Rating ) had its price objective lowered by analysts at Morgan Stanley from $56.00 to $52.00 in a report issued on Tuesday, Stock Target Advisor reports. The brokerage presently has an “overweight” rating on the industrial products company’s stock. Morgan Stanley’s price objective indicates a potential upside of 9.91% from the company’s current price.IR has been the topic of a ...
5/31/2022 Morgan Stanley updates biotechs with negative enterprise values & 2022 catalysts Seeking Alpha ... Morgan Stanley updates biotechs with negative enterprise values & 2022 catalysts[Galapagos NV (GLPG)][GLPGF] , , , , , , , , , , , , , , , , , , , , , , , , , , By:[Dulan Lokuwithana] , SA News Editor[1 Comment]Reviewing its coverage on biotechs with negative enterprise values, Morgan Stanley says that the number of companies on the list with potential catalysts in 2022 has increased to 27 in May from 20 previously.Adding market capitalization to total debt and deducting cash and cash equivalents, the enterprise ...
5/31/2022 Ingersoll Rand (NYSE:IR) Given New $52.00 Price Target at Morgan Stanley modernreaders.com Ingersoll Rand ( NYSE:IR – Get Rating ) had its price objective lowered by analysts at Morgan Stanley from $56.00 to $52.00 in a report issued on Tuesday, Stock Target Advisor reports. The brokerage presently has an “overweight” rating on the industrial products company’s stock. Morgan Stanley’s price objective indicates a potential upside of 9.91% from the company’s current price.IR has been the topic of a ...
5/31/2022 Emerson Electric (NYSE:EMR) PT Lowered to $95.00 at Morgan Stanley modernreaders.com Emerson Electric ( NYSE:EMR – Get Rating ) had its target price cut by investment analysts at Morgan Stanley from $101.00 to $95.00 in a note issued to investors on Tuesday, Stock Target Advisor reports. The firm presently has an “equal weight” rating on the industrial products company’s stock. Morgan Stanley’s target price would indicate a potential upside of 8.18% from the company’s current price.Several other ...
5/30/2022 Medtronic (NYSE:MDT) PT Lowered to $115.00 at Morgan Stanley American Banking News Medtronic ( NYSE:MDT – Get Rating ) had its price objective lowered by Morgan Stanley from $120.00 to $115.00 in a report published on Friday morning, Stock Target Advisor reports. Morgan Stanley currently has an equal weight rating on the medical technology company’s stock.MDT has been the topic of a number of other research reports. Cowen raised their target price on shares of Medtronic to $125.00 in a report ...
5/30/2022 Morgan Stanley Cuts AmerisourceBergen (NYSE:ABC) Price Target to $175.00 zolmax.com AmerisourceBergen ( NYSE:ABC – Get Rating ) had its target price lowered by Morgan Stanley from $178.00 to $175.00 in a research note released on Friday, Stock Target Advisor reports. The brokerage currently has an equal weight rating on the stock.ABC has been the topic of several other reports. Deutsche Bank Aktiengesellschaft lowered their target price on shares of AmerisourceBergen from $168.00 to $167.00 in a research report on Wednesday ...
5/30/2022 AmerisourceBergen (NYSE:ABC) Price Target Lowered to $175.00 at Morgan Stanley - Watch List News watchlistnews.com AmerisourceBergen ( NYSE:ABC – Get Rating ) had its price target cut by Morgan Stanley from $178.00 to $175.00 in a report published on Friday, Stock Target Advisor reports. They currently have an equal weight rating on the stock.ABC has been the topic of several other research reports. Barclays raised shares of AmerisourceBergen from an equal weight rating to an overweight rating and lifted their price objective for the stock ...
5/29/2022 Morgan Stanley Increases Cigna (NYSE:CI) Price Target to $283.00 - Ticker Report Ticker Report Cigna ( NYSE:CI – Get Rating ) had its target price increased by stock analysts at Morgan Stanley from $235.00 to $283.00 in a research note issued to investors on Friday, The Fly reports. The firm currently has an “equal weight” rating on the health services provider’s stock. Morgan Stanley ’s target price would indicate a potential upside of 3.89% from the company’s current price.CI has been ...
5/29/2022 UDR (NYSE:UDR) Price Target Lowered to $51.00 at Morgan Stanley com-unik.info UDR ( NYSE:UDR – Get Rating ) had its price target cut by Morgan Stanley from $56.00 to $51.00 in a research report sent to investors on Wednesday, Stock Target Advisor reports. They currently have an equal weight rating on the real estate investment trust’s stock.Other equities analysts also recently issued research reports about the stock. StockNews.com initiated coverage on shares of UDR in a report on Thursday, March ...
5/29/2022 Snowflake (NYSE:SNOW) PT Lowered to $295.00 at Morgan Stanley Daily Political Snowflake (NYSE:SNOW) PT Lowered to $295.00 at Morgan Stanley Posted by Latisha Jones on May 29th, 2022 Share on StocktwitsSnowflake ( NYSE:SNOW – Get Rating ) had its price target decreased by Morgan Stanley from $322.00 to $295.00 in a research report released on Thursday, The Fly reports. Morgan Stanley currently has an overweight rating on the stock.A number of other analysts have also commented on the company ...
5/28/2022 Pfizer Inc. (NYSE:PFE) Shares Acquired by Red Door Wealth Management LLC - The Cerbat Gem thecerbatgem.com ... quarter.A number of other hedge funds also recently made changes to their positions in PFE. OLD Mission Capital LLC acquired a new stake in Pfizer during the third quarter valued at approximately $291,000. Morgan Stanley raised its stake in Pfizer by 3.4% during the second quarter. Morgan Stanley now owns 47,894,080 shares of the biopharmaceutical company’s stock valued at $1,875,532,000 after buying an additional 1,582,052 shares in the ...
5/28/2022 National Health Investors, Inc. (NYSE:NHI) Shares Bought by abrdn plc - Ticker Report Ticker Report ... 2.5% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 79,619 shares of the real estate investment trust’s stock worth $6,254,000 after purchasing an additional 1,960 shares in the last quarter. Morgan Stanley lifted its position in shares of National Health Investors by 25.1% during the second quarter. Morgan Stanley now owns 186,396 shares of the real estate investment trust’s stock worth $12,497,000 after purchasing an ...